Sign in Pull a receipt

JNJ

JOHNSON & JOHNSON

Health Care · Pharmaceuticals

$200.61 sample

+0.74 (+0.37%) 1D

Market cap

$514.9B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-26

Alerts

8

Price$200.61 +7.48% 3M daily closessample

203.10179.63

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26SEC10-Q filed
Oct 15INSInsider sell: General Counsel
Oct 06INSInsider sell: 10% owner
Sep 28INSInsider sell: EVP, Operations
Sep 23INSInsider sell: Chief Executive Officer
Sep 14SECDEF 14A filed
Sep 08INSInsider sell: EVP, Operations
Sep 02SEC8-K filed: material event

Sign up to see the real JNJ record →

Company facts

SEC EDGAR registration

Name: JOHNSON & JOHNSON
Sector: Health Care
Industry: Pharmaceuticals
Smart-money score: +56sample, -100 to +100
Reporting currency: USD

Who is positioning in JNJ

sample

Insiders: 26 insider transactions over 90 days, net selling, $298.6M
Congress: No member trades over 90 days
Institutions · 13F: 23 funds hold $8.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$22.5B +13.5% y/y

Q4 2024Q3 2026

Inventory$14.1B +14.6% y/y

Q4 2024Q3 2026

Accounts receivable$10.4B +14.4% y/y

Q4 2024Q3 2026

Total debt$28.4B +13.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $233.9B +1.3% 3M
Sample peer B: $230.8B -8.3% 3M
Sample peer C: $393.6B +9.1% 3M
Sample peer D: $363.1B +8.9% 3M
Sample peer E: $268.7B +13.1% 3M